Becton, Dickinson and Co. | BDX - Ebit

Stock Price
154.51
Daily Change
-1.83 -1.17%
Monthly
-11.31%
Yearly
-30.27%
Q2 Forecast
149.86

Becton, Dickinson and Co. reported $663M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Abbott USD 2.54B 358M Dec/2025
Agilent USD 353M 90M Dec/2025
Align Technology USD 224.71M 40.06M Dec/2025
AngioDynamics USD -2.51M 5.41M Sep/2025
Avanos Medical USD 24.77M 5.8M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Bio-Rad Laboratories USD -418.8M 845.4M Sep/2025
Boston Scientific USD 1.24B 203M Dec/2025
Cooper Companies USD 212.8M 72.4M Dec/2025
Danaher USD 1.5B 348M Dec/2025
Dentsply International USD 538M 26M Dec/2025
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
Globus Medical USD 181.31M 298.83M Dec/2025
Hologic USD 240.9M 12.1M Dec/2025
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 66M 54.24M Dec/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
J&J USD 5.11B 2.3B Dec/2025
Masimo USD 83.9M 200K Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Solventum Corp USD 105M 1.58B Dec/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 76.31M Dec/2025
Terumo JPY 43.88B 1.21B Dec/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025